Home / Inspections / 1053034

FDA Inspection 1053034 — Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited — FEI 3008565058

The FDA completed an inspection of Glenmark Pharmaceuticals Limited on May 24, 2018 in Dhar. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 24, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dhar (India)

Facility

Other inspections at this facility

  • 1260403 (OAI Fri Feb 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1122868 (NAI Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1107098 (NAI Fri Sep 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1028538 (NAI Sat Aug 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 962557 (VAI Fri Feb 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources